1-(5-isoquinolinesulfonyl)-2-methylpiperazine and lrrk2-in1

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with lrrk2-in1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Froehlich, T; Gillardon, F; Gloeckner, CJ; Hengerer, B; Kremmer, E; Ueffing, M1

Other Studies

1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and lrrk2-in1

ArticleYear
ATP-competitive LRRK2 inhibitors interfere with monoclonal antibody binding to the kinase domain of LRRK2 under native conditions. A method to directly monitor the active conformation of LRRK2?
    Journal of neuroscience methods, 2013, Mar-30, Volume: 214, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Amino Acid Sequence; Amino Acid Substitution; Animals; Antibodies, Monoclonal; Antigen-Antibody Reactions; Benzodiazepinones; Binding, Competitive; Enzyme Activation; Epitopes; HEK293 Cells; Humans; Immunoprecipitation; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Parkinson Disease; Phosphorylation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Pyrimidines; Recombinant Proteins; Swiss 3T3 Cells

2013